HIA
MRNA icon

HFM Investment Advisors’s Moderna MRNA Stock Holding History

HFM Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Buy
20
+12
+150% +$621 ﹤0.01% 605
2026
Q1 		$406 Buy
8
+7
+700% +$327 ﹤0.01% 752
2025
Q4 		$30 Hold
1
– – ﹤0.01% 1253
2025
Q3 		$26 Sell
1
-1
-50% -$28 ﹤0.01% 1245
2025
Q2 		$55 Buy
+2
New +$53 ﹤0.01% 1211

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

HFM Investment Advisors's MRNA Position: Q2 2026 in Review

HFM Investment Advisors increased its Moderna (MRNA) stake by 150% in Q2 2026, buying an estimated $621 and bringing the position to 20 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #605.

HFM Investment Advisors first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • HFM Investment Advisors held 20 shares of Moderna worth $1.4K as of Q2 2026.
  • HFM Investment Advisors bought 12 Moderna shares in Q2 2026, an estimated $621.
  • Moderna made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #605 holding.
  • HFM Investment Advisors first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.